Proton Pump Inhibitors Modulate Transport of Doxorubicin and Its Liposomal Form Into 2D and 3D Breast Cancer Cell Cultures

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s224097
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Editorial: Proton Pump Inhibitors (PPIs) and Primary Liver Cancer

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy

OnCOReview
Oncology
2017English

Proton Pump Inhibitors and Gastric Neoplasia

Gut
Gastroenterology
2006English

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Pleotropic Effects of Proton Pump Inhibitors Guest Editor: Yuji Naito Gastric Epithelial Cell Modality and Proton Pump Inhibitor

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2008English

2d- And 3d-Based Intestinal Stem Cell Cultures for Personalized Medicine

Cells
2018English

Community-Acquired Pneumonia and Proton Pump Inhibitors

Journal of General Internal Medicine
Internal Medicine
2013English

Interaction Between Clopidogrel and Proton Pump Inhibitors

CMAJ
Medicine
2009English

Proton Pump Inhibitors and Osteoporosis-Related Fractures

CMAJ
Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy